top of page
Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Jul 28
Emory doctor hopeful about clinical trial for new skin cancer treatment
https://www.msn.com/en-us/health/other/emory-doctor-hopeful-about-clinical-trial-for-new-skin-cancer-treatment/ar-BB1oTdCU?ocid=BingNewsVerp
Jul 6
Jun 10
“We are a game changer for cancer treatment ” CEO Uzi Sofer - Impact Nation
Alpha Tau delivers powerful radiation directly to tumors for treatment that is both more effective and gentler.
Apr 19
Beer Tanning TikTok Trend Should Stay in 2023 - Healthnews
And now for something a bit different! Our Chief Medical Officer, Dr. Robert Den, MD, a renowned authority when it comes to cancer, was...
Sep 14, 2023
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Hadassah Medical Center
JERUSALEM, Sept. 14, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Aug 29, 2023
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR,...
Aug 24, 2023
Alpha Tau Medical to Participate in September Investor Conferences
JERUSALEM, August 24, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Aug 21, 2023
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha
- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate. - Two-year...
Aug 2, 2023
Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023
JERUSALEM, August 02, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Apr 3, 2023
Alpha Tau & JGH Announce Alpha Dart treatment of First Patient in Pancreatic Cancer Clinical Trial
-First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of...
bottom of page